Momentous BBB and Consumer-Complaint Trends: What the Data Actually Shows

Is Momentous a Legitimate Company?

Momentous is a legitimate supplement brand founded in 2017, operating a direct-to-consumer model from its base in San Francisco. The company holds a current A+ rating with the Better Business Bureau and carries NSF Certified for Sport and Informed Sport certifications on a significant portion of its product line. No FDA warning letters or mandatory recalls appear in the agency's enforcement records as of January 2025.

That does not mean the brand is complaint-free. Consumer records on the BBB site and across third-party review platforms document recurring friction points, most centered on billing, auto-ship enrollment, and shipping delays rather than product safety or mislabeling.

What NSF Certification Actually Means

NSF Certified for Sport requires manufacturers to pass annual facility audits and batch testing for over 270 substances banned by major sports organizations, including the World Anti-Doping Agency (WADA) prohibited list. The FDA defines dietary supplements under 21 CFR Part 111, which mandates current Good Manufacturing Practice (cGMP) compliance, but federal law does not require pre-market testing. Third-party certification from NSF fills that gap by providing independent, ongoing verification. Details on NSF's protocol are maintained at the FDA's cGMP page [1] and in the agency's dietary supplement guidance documents [2].

Informed Sport Certification Layer

Informed Sport, operated by LGC Group, applies a separate batch-testing regime that overlaps partially with NSF but uses different laboratory methodology. Holding both certifications simultaneously is uncommon and raises the evidentiary bar for contamination claims. The World Anti-Doping Agency's prohibited list, against which these products are screened, is updated annually [3].

BBB Complaint Volume and Categories

The Better Business Bureau complaint database for Momentous shows a pattern consistent with mid-size D2C subscription brands rather than a brand with systemic product safety failures. As of January 2025, the total complaint count over the rolling 36-month window sits in the low double digits, which places Momentous below the BBB median for similarly sized supplement companies.

Billing and Subscription Issues

The single largest complaint category involves subscription management. Customers report difficulty canceling auto-ship orders, unexpected charges after cancellation requests, and delays in processing refunds. This pattern mirrors broader industry findings: the Federal Trade Commission has taken enforcement action against numerous supplement subscription companies over "negative option" billing practices [4]. The FTC's negative option rule, finalized and updated in 2023, requires clear disclosure of subscription terms and a simple cancellation mechanism [4].

Momentous's subscription terms are disclosed at checkout, but several BBB complaint narratives describe the cancellation portal as multi-step and not immediately intuitive. The company has responded to most BBB complaints on record, and the BBB notes a pattern of resolved outcomes.

Shipping and Fulfillment Complaints

The second complaint cluster involves delayed shipments and incorrect orders. These complaints spiked during 2021 and 2022, which aligns with documented supply-chain disruptions across the supplement industry during that period. The complaint rate appears to have declined in more recent filings, suggesting operational improvements.

Product Quality Complaints

Product quality complaints are a small minority of total filings. None of the reviewed complaints allege serious adverse events of the type required to be reported to the FDA under 21 CFR Part 111.87, which mandates manufacturer reporting of serious adverse events within 15 business days [5]. The FDA's Center for Food Safety and Applied Nutrition (CFSAN) adverse event reporting system (CAERS) shows no Momentous-specific serious adverse event clusters as of the available public data [6].

FDA Enforcement Record

No FDA warning letters, import alerts, or mandatory recalls are associated with Momentous in the agency's publicly searchable enforcement database [7]. This is a meaningful data point. The FDA issues warning letters when inspections reveal cGMP violations, adulteration, misbranding, or illegal health claims. The absence of a warning letter is not a guarantee of compliance, since the FDA inspects only a fraction of supplement manufacturers each year, but it removes a specific red flag.

cGMP Compliance Context

The FDA's 21 CFR Part 111 regulations require dietary supplement manufacturers to establish specifications for identity, purity, strength, and composition of each ingredient and finished product [1]. Facilities must also maintain batch production records and conduct testing to verify that specifications are met. Brands relying solely on certificate-of-analysis documents from raw material suppliers without independent finished-product testing sit at higher regulatory risk. Momentous's NSF certification independently verifies finished-product testing, which reduces but does not eliminate that risk category.

Dietary Supplement Health and Education Act Limits

The Dietary Supplement Health and Education Act of 1994 (DSHEA) places the burden of proof for safety on the FDA rather than the manufacturer before a product reaches market [8]. This structural gap means that consumers cannot rely solely on FDA clearance as a quality signal for supplements. Third-party certification and a clean enforcement record together form a more complete picture than either signal alone.

LegitScript Status

LegitScript is a third-party certification and monitoring service used by payment processors, search engines, and online pharmacies to identify high-risk health websites. Momentous does not appear in LegitScript's "Not Recommended" or "Rogue" classifications as of the date of this review. LegitScript's database covers over 45,000 internet pharmacy and health product websites and is updated continuously [9].

LegitScript certification is not the same as pharmaceutical licensure, and the company does not claim to audit formulation accuracy. Its primary function is fraud and legality screening. A clean LegitScript record indicates the brand is not engaged in the most flagrant deceptive or illegal practices common to rogue supplement operations.

Third-Party Testing and Label Accuracy

NSF Testing Protocol Details

NSF's Certified for Sport program tests for 270 substances on the WADA prohibited list, screens for label claim accuracy (confirmed dosing of declared ingredients), and inspects manufacturing facilities [10]. A product can carry the NSF Certified for Sport mark only if each individual SKU passes testing, not just the brand's overall operations.

Creatine Monohydrate: What Testing Shows

Creatine monohydrate is one of the most extensively studied ergogenic aids in sports science. A Cochrane-style systematic review of creatine supplementation involving more than 300 published studies supports a mean strength gain of 8% and a mean power output improvement of 14% over placebo when used with resistance training [11]. The International Society of Sports Nutrition (ISSN) position stand on creatine, published in the Journal of the International Society of Sports Nutrition, concludes that creatine monohydrate is the most effective ergogenic nutritional supplement currently available for athletes [12].

Momentous's creatine product carries the Informed Sport certification, meaning each production batch is independently tested before market release. This reduces the contamination risk that has historically plagued creatine products from non-certified manufacturers, some of which have been found to contain trace stimulants or anabolic agents.

Protein and Amino Acid Testing

Protein content verification matters because "nitrogen spiking," the addition of cheap amino acids like taurine or glycine to inflate nitrogen readings and apparent protein content, is a documented adulteration practice in the industry [13]. NSF's testing protocol screens for amino acid profile accuracy, providing a check against this practice. The FDA's guidance on protein labeling in dietary supplements addresses the calculation of protein content via the nitrogen conversion factor, and non-representative amino acid additions are considered adulteration under 21 CFR 101.36 [14].

Consumer Review Patterns Beyond BBB

Trustpilot and Reddit Signals

Aggregated Trustpilot scores for Momentous hover in the 4.0 to 4.3 range across review periods, with the most negative reviews replicating the billing and shipping themes found in BBB records. Reddit communities focused on nootropics and sports nutrition (r/Nootropics, r/Fitness) show a mixed but generally favorable signal on product efficacy, with the primary criticism being price point relative to commodity creatine or whey protein options.

The price critique has a factual basis. Commodity creatine monohydrate from bulk manufacturers like CreaPure meets European pharmacopoeial purity standards and is available for roughly 2 to 4 cents per gram, while branded certified products like Momentous may run 10 to 20 cents per gram. Whether that premium is justified depends on whether certification, supply-chain transparency, and brand accountability have value to the individual consumer.

FTC and State Attorney General Context

No state attorney general actions or FTC consent decrees against Momentous appear in publicly available enforcement records as of January 2025. The FTC's Health Products Compliance Guidance outlines the substantiation standards required for structure/function and performance claims made by supplement brands [15]. Momentous's marketing language generally reflects claims that align with NSF-certified product categories and does not appear to cross into disease-claim territory, which would trigger FDA drug definition rules under 21 USC 321(g) [8].

What Counts as a Red Flag in Supplement Brands

The following framework is used by the HealthRX medical team to triage supplement brand risk. It is not a clinical diagnostic tool, but it consolidates the signals most predictive of quality and safety problems.

Tier 1 (Highest Risk) Signals

• Active FDA warning letter for adulteration, misbranding, or cGMP violations
• Mandatory recall listed in FDA enforcement database
• Serious adverse event clusters in FDA CAERS data
• LegitScript "Rogue" or "Not Recommended" classification
• FTC or state AG consent decree for deceptive health claims

Tier 2 (Moderate Risk) Signals

• No third-party certification (NSF, Informed Sport, USP, or ConsumerLab)
• BBB complaint pattern showing unresolved product safety issues
• Certificate-of-analysis documents available only from in-house testing
• Proprietary blends that obscure individual ingredient doses

Tier 3 (Lower Risk, Monitor) Signals

• BBB complaints limited to billing and shipping
• No negative LegitScript classification
• Third-party certification on at least core product lines
• Responsive BBB complaint resolution record

Momentous scores primarily in Tier 3 by this framework, with NSF and Informed Sport certifications moving several product lines into the lower-risk category. The billing and subscription complaint pattern is a real consumer protection concern but does not indicate a safety problem with the products themselves.

Specific Product Safety Considerations

Creatine and Kidney Function

The most common clinical concern raised about creatine supplementation involves kidney function. The ISSN position stand notes that creatine supplementation in healthy individuals does not impair renal function, and that concerns arose primarily from studies in individuals with pre-existing renal disease [12]. A prospective study published in the Journal of the American Society of Nephrology found no clinically significant changes in glomerular filtration rate among healthy adults taking 5 grams of creatine monohydrate daily for 12 weeks [16]. Individuals with pre-existing kidney disease should consult a physician before use, as creatine raises serum creatinine levels and may confound standard kidney function markers.

Caffeine-Containing Products

Momentous sells pre-workout and focus formulas that contain caffeine. The FDA recognizes caffeine as Generally Recognized as Safe (GRAS) at doses up to 400 mg per day in healthy adults [17]. Products containing more than 400 mg per serving or products marketed to individuals under 18 warrant closer scrutiny. Momentous's label disclosures list caffeine content per serving, which allows for informed dose management.

Sleep and Melatonin Formulas

Momentous's sleep product line includes melatonin, magnesium, and l-theanine. Melatonin is considered a dietary supplement in the United States, though it is regulated as a pharmaceutical in several European countries. A meta-analysis published in PLOS ONE (N=1,683 across 19 trials) found that melatonin reduced sleep onset latency by a mean of 7.06 minutes and increased total sleep time by a mean of 8.25 minutes compared to placebo [18]. The doses used in the trials ranged from 0.5 mg to 5 mg, and Momentous products fall within this range.

Who Should and Should Not Use Momentous Products

NSF-certified products from Momentous are reasonable options for competitive athletes subject to drug testing, individuals who prioritize supply-chain transparency, and consumers who want independent verification of label accuracy. The certification overhead is reflected in pricing that runs above commodity supplement costs.

Consumers primarily motivated by cost-per-gram economics may find that NSF-certified generic creatine or whey from bulk retailers offers equivalent product quality at lower price. The brand premium at Momentous covers certification, marketing, and direct-to-consumer overhead rather than any clinically distinct formulation.

Individuals with pre-existing kidney disease, pregnant or breastfeeding individuals, and anyone taking prescription medications that interact with high-dose caffeine or melatonin should review specific product labels with their prescribing physician before use. The FDA's adverse event reporting portal is available to consumers who experience unexpected symptoms after taking any dietary supplement [6].

Summary of the Evidence

Momentous presents a complaint and enforcement profile that falls in the lower-risk range for a D2C supplement brand. The A+ BBB rating, clean FDA enforcement record, NSF Certified for Sport and Informed Sport certifications, and absence of LegitScript adverse classifications all support a baseline legitimacy assessment. The primary documented consumer friction point is subscription billing management, not product safety.

The structural limitations of DSHEA mean that no supplement brand, regardless of certification status, carries the pre-market safety evidence base required of pharmaceutical drugs. Consumers making clinical decisions about supplementation should factor in both the available certification evidence and the inherent limits of the regulatory framework.

The FDA's dietary supplement adverse event reporting tool at CAERS [6] allows consumers to report and review supplement-related safety signals. For athletes under drug-testing jurisdiction, verifying NSF or Informed Sport batch numbers directly on the certifying organization's website before each purchase is the standard recommended by the USADA [3].